Clinical Trials Sponsored by Mental Health Centre Sct. Hans

Total 2309 results

Mental Health Centre Sct. Hans

Not yet recruiting

VR Based Therapy to Treat Anxiety in Dual Diagnosis

Substance Use Disorder | Psychosis | Social Anxiety Disorder | Dual Diagnosis | Agoraphobia
Central South University
Shanghai Mental Health Center

Active, not recruiting

rTMS on Appetite and Cognitive Function in Schizophrenia

Schizophrenia

China
Central South University
Shanghai Mental Health Center

Active, not recruiting

cTBS on First-episode Drug Naive Patients With Schizophrenia

Schizophrenia

China
Central Institute of Mental Health, Mannheim

Not yet recruiting

Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption (NeuStress)

Craving | Alcohol Abuse | Psychosocial Stressor | Neural Stress Response

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder (A03)

Risk Behavior | Alcohol Use Disorder | Craving | Relapse | Stress Reaction | Social Stress | Addiction, Alcohol

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Selective Attention in Alcohol Use Disorder

Alcohol Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Electroconvulsive Therapy for Treatment of Alzheimer´s Disease (ECTAD)

Alzheimer's Disease
Central Institute of Mental Health, Mannheim

Completed

Evaluation of the Addictive Potential of E-Cigarettes (EVAPE)

Tobacco Use Disorder | Nicotine Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Amitriptyline and Paroxetine Treatment of Major Depression

Unipolar Depression

Germany
Central Institute of Mental Health, Mannheim

Completed

Modification of Goal-directed and Habitual Behavior in Addiction

Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Investigation of Brain Oxygenation and Blood Flow in Smokers (OEF)

Cerebral Oxygenation and Blood Flow in Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Neural and Pharmacological Correlates of Intrusions in Patients With Posttraumatic Stress Disorder

Posttraumatic Stress Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids

Healthy | Modeling Psychosis

Germany
Central Institute of Mental Health, Mannheim

Completed

Effects of THC and CBD on Human Episodic Memory Function

Healthy Volunteers

Germany
Central Institute of Mental Health, Mannheim

Completed

Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine

Psychotic Disorders

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial (MECT-RESIST)

Schizophrenia | Treatment Resistant Schizophrenia

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation

Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia

Schizophrenia

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Enhancing Recovery in Early Schizophrenia

Schizophrenia

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study

Healthy Volunteers | Modeling Psychosis

Germany
Central Institute of Mental Health, Mannheim

Active, not recruiting

Validation of a Training Program for Patients With Alcohol Use Disorder

Alcohol Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Neurobiological Mechanisms of Chess as an Add-On Treatment Against SUD (Chess_SUD)

Substance Use Disorders

Germany
Central Institute of Mental Health, Mannheim

Completed

Targeted Extinction of Drug Cues During Sleep - Olfactory Cue Reactivity Task (TEDDS_OCRT)

Heavy Drinking

Germany
Central Institute of Mental Health, Mannheim

Completed

Reversing Maladaptive Reorganization in Frail Brains (FRAILBRAIN)

Neuroplasticity | Sensorimotor

Germany
Central Institute of Mental Health, Mannheim

Completed

Transcranial Direct Current Stimulation - Tobacco Use Disorder

Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Terminated

Cannabidiol - an in Vivo Innovative Drug Delivery Study

Pharmacokinetics, Bioavailability

Germany
Central Institute of Mental Health, Mannheim

Completed

Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain

Chronic Lower Back Pain | Healthy Control Subjects

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Substance Consumption, Personality, and Cognitive Functioning of Chess Players

Depression | Anxiety | Addiction | Nicotine | Personality | Alcohol | Drugs

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Modification of Cue Reactivity by Neurofeedback in Human Addiction

Alcohol Use Disorder (AUD)

Germany
Central Institute of Mental Health, Mannheim

Completed

Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents

Aggression | Conduct Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Training of Neural Responding in BPD (IP5n)

Borderline Personality Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (AB_THC_CBD)

Healthy Humans

Germany
Central Institute of Mental Health, Mannheim

Unknown

Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe PTSD Following Sexual Abuse (PASA)

Posttraumatic Stress Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Schizophrenia, Schizoaffective Disorder

Germany
Central Institute of Mental Health, Mannheim

Terminated

Naltrexone in Borderline Personality Disorder

Borderline Personality Disorder

Germany
Central South University
Shanghai Mental Health Center; Capital Medical University; Guangzhou Mental Hospital and other collaborators

Completed

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Schizophrenia

China
Shanghai Mental Health Center
Xuhui Mental Health Center

Recruiting

Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia

Schizophrenia | Cognitive Impairment | Repetitive Transcranial Magnetic Stimulation | Negative Symptoms in Schizophrenia | Dorsolateral Prefrontal Cortex

China
Shalvata Mental Health Center
Geha Mental Health Center

Unknown

Optimizing the Resources of Psychotherapy as a Tool for Implementing the Mental Health Reform

Psychotherapy Research and Outcome Measures
Shalvata Mental Health Center
Abarbanel Mental Health Center

Completed

Minocycline for the Treatment of Early-Phase Schizophrenia

Negative and Cognitive Symptoms in Schizophrenia

Israel
Shanghai Mental Health Center
Qingdao Mental Health Center

Active, not recruiting

Effect Analysis of Physical Therapy Based on Electronic Medical Record

Physical Therapy

China
Central Institute of Mental Health, Mannheim
Servier

Completed

Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) (AGOPSYCH)

Schizophrenia | Schizoaffective Disorder | Delusional Disorder

Germany
Central Institute of Mental Health, Mannheim
Sanofi

Completed

Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism

Diabetes | Schizophrenia | Insulin Resistance

Germany
Beersheva Mental Health Center
Tirat Carmel Mental Health Center; Sha'ar Menashe Mental Health Center

Withdrawn

Pyridoxal Kinase Activity in Tardive Dyskinesia

Tardive Dyskinesia

Israel
Sha'ar Menashe Mental Health Center
Beersheva Mental Health Center

Completed

Pregnenolone in the Management of Schizophrenia Patients

Schizophrenia

Israel
Wuhan Mental Health Centre

Not yet recruiting

Machine Learning-based Classification of Symptom Clusters and Online CBT

Depression and Anxiety Symptom
Wuhan Mental Health Centre

Active, not recruiting

A Study on the Outcome and Its Influencing Factors in Patients With Borderline Personality Disorder

Borderline Personality Disorder

China
Shalvata Mental Health Center
Beer Yaakov Mental Health Center

Unknown

Neuromarkers Identification in Major Depressive Disorder Based on Monitoring Measures

Depression

Israel
Beersheva Mental Health Center
Tirat Carmel Mental Health Center

Completed

Metoclopramide as Treatment of Clozapine-induced Hypersalivation

Clozapine-induced Hypersalivation

Israel
Beersheva Mental Health Center
Tirat Carmel Mental Health Center

Completed

Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation (CIH)

Clozapine-induced Hypersalivation

Israel
Beersheva Mental Health Center
Tirat Carmel Mental Health Center

Completed

Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

Chronic Schizophrenia

Israel

Clinical Trials Sponsored by Mental Health Centre Sct. Hans

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations